Key result
In diabetic men, ECG-defined silent coronary heart disease was associated with a increased risk of cardiovascular events compared to those with normal ECGs.
Why the study?
Does ECG-defined silent CHD predict cardiovascular events in patients with type 2 diabetes?
Cohort (n=926)
Does ECG-defined silent CHD predict cardiovascular events in patients with type 2 diabetes?
ECG-defined silent CHD is a significant predictor of cardiovascular events in diabetic men, supporting ADA recommendations for further cardiac testing in this subgroup.
Answers are grounded in this paper and cite their sources.
May aid risk stratification in diabetic men; leaves open whether screening or intervention improves outcomes.
BACKGROUND: We assessed the clinical outcomes of symptomatic and asymptomatic coronary heart disease (CHD) with type 2 diabetic patients. DESIGN: Population-based cohort study. METHODS: The study sample consisted of 380 men and 546 women, aged ≥30 years. Silent CHD was defined using Minnesota coding criteria on baseline electrocardiogram (ECG), in the absence of a history of CHD and symptoms of angina. Participants were categorized into four groups: group 1, participants with no CHD symptoms and with normal ECG; group 2, silent CHD; group 3, participants with symptomatic CHD but with normal ECG; group 4, participants with symptomatic CHD and ECG-determined CHD. Cox regression analysis was used to estimate the hazard ratios (HRs) of cardiovascular disease (CVD) and CHD events for these groups, with group 1 as the reference. RESULTS: During median follow up of 9.2 years, we ascertained 226 CVD events (202 CHD). In the multivariable-adjusted model, among men, HRs (95% CI) of CVD events were 2.32 (1.29-4.16), 2.56 (1.47-4.46), and 3.97 (2.24-7.02) for groups 2, 3, and 4, respectively; the corresponding figures among women were 1.19 (0.65-2.18), 1.90 (1.24-2.92), and 1.92 (1.02-3.62) respectively. Similar results were achieved for CHD events. CONCLUSION: In both sexes, symptomatic CHD was an independent predictor of recurrent CVD/CHD, regardless of ECG results. In diabetic men with asymptomatic CHD, ECG could be of prognostic value for incident CVD/CHD. The present study provides evidence-based support only in men for the ADA recommendation of 'further cardiac testing for diabetic patients with an abnormal resting ECG'.
No takes yet. Share an insight, caveat, or question.
Hadaegh et al. (2011) conducted a cohort in Type 2 diabetes (n=926). Electrocardiography-defined silent CHD vs. No CHD symptoms and normal ECG was evaluated on Cardiovascular disease (CVD) events (HR 2.32, 95% CI 1.29-4.16). In diabetic men, ECG-defined silent coronary heart disease was associated with a increased risk of cardiovascular events compared to those with normal ECGs.
Synapse has enriched 10 related papers. Consider them for comparative context: